3D Printed Tablets (Printlets) with Braille and Moon Patterns for Visually Impaired Patients

被引:108
作者
Awad, Atheer [1 ]
Yao, Aliya [1 ]
Trenfield, Sarah J. [1 ]
Goyanes, Alvaro [2 ,3 ]
Gaisford, Simon [1 ,2 ]
Basit, Abdul W. [1 ,2 ]
机构
[1] UCL, UCL Sch Pharm, Dept Pharmaceut, 29-39 Brunswick Sq, London WC1N 1AX, England
[2] FabRx Ltd, 3 Romney Rd, Ashford TN24 0RW, Kent, England
[3] Univ Santiago de Compostela, Dept Farmacol Farm & Tecnol Farmaceut, I D Farma Grp GI 1645, Santiago De Compostela 15782, Spain
基金
英国工程与自然科学研究理事会;
关键词
three-dimensional printing; 3D printed drug products; orally disintegrating tablets; personalised medicines; personalized pharmaceuticals; blindness; visual deprivation; touch-reading compliance; tactile patterns; sight loss; SIMILARITY FACTOR; DOSAGE FORMS; RELEASE; DEVICES; SCAFFOLD; VISION;
D O I
10.3390/pharmaceutics12020172
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Visual impairment and blindness affects 285 million people worldwide, resulting in a high public health burden. This study reports, for the first time, the use of three-dimensional (3D) printing to create orally disintegrating printlets (ODPs) suited for patients with visual impairment. Printlets were designed with Braille and Moon patterns on their surface, enabling patients to identify medications when taken out of their original packaging. Printlets with different shapes were fabricated to offer additional information, such as the medication indication or its dosing regimen. Despite the presence of the patterns, the printlets retained their original mechanical properties and dissolution characteristics, wherein all the printlets disintegrated within similar to 5 s, avoiding the need for water and facilitating self-administration of medications. Moreover, the readability of the printlets was verified by a blind person. Overall, this novel and practical approach should reduce medication errors and improve medication adherence in patients with visual impairment.
引用
收藏
页数:14
相关论文
共 70 条
[1]   Emergence of 3D Printed Dosage Forms: Opportunities and Challenges [J].
Alhnan, Mohamed A. ;
Okwuosa, Tochukwu C. ;
Sadia, Muzna ;
Wan, Ka-Wai ;
Ahmed, Waqar ;
Arafat, Basel .
PHARMACEUTICAL RESEARCH, 2016, 33 (08) :1817-1832
[2]   Understanding the effects of formulation and process variables on the printlets quality manufactured by selective laser sintering 3D printing [J].
Ali, Sogra F. Barakh ;
Mohamed, Eman M. ;
Ozkan, Tanil ;
Kuttolamadom, Mathew A. ;
Khan, Mansoor A. ;
Asadi, Amir ;
Rahman, Ziyaur .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2019, 570
[3]   Selective Laser Sintering 3D Printing of Orally Disintegrating Printlets Containing Ondansetron [J].
Allahham, Nour ;
Fina, Fabrizio ;
Marcuta, Carmen ;
Kraschew, Lilia ;
Mohr, Wolfgang ;
Gaisford, Simon ;
Basit, Abdul W. ;
Goyanes, Alvaro .
PHARMACEUTICS, 2020, 12 (02)
[4]  
[Anonymous], [No title captured]
[5]  
[Anonymous], 2013, GENEREVIEWS
[6]  
Apoorva R., 2017, INT J BASIC AMP CLIN, V6, P10
[7]  
ApreciaPharmaceutials, WHAT IS ZIPDOSE TECH
[8]   3D Printed Pellets (Miniprintlets): A Novel, Multi-Drug, Controlled Release Platform Technology [J].
Awad, Atheer ;
Fina, Fabrizio ;
Trenfield, Sarah J. ;
Patel, Pavanesh ;
Goyanes, Alvaro ;
Gaisford, Simon ;
Basit, Abdul W. .
PHARMACEUTICS, 2019, 11 (04)
[9]   Reshaping drug development using 3D printing [J].
Awad, Atheer ;
Trenfield, Sarah J. ;
Goyanes, Alvaro ;
Gaisford, Simon ;
Basit, Abdul W. .
DRUG DISCOVERY TODAY, 2018, 23 (08) :1547-1555
[10]  
Barnatt C., 2016, 3D printing